-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Nuvation Bio, Raises Price Target to $18

Benzinga·12/11/2025 11:22:40
語音播報
HC Wainwright & Co. analyst Robert Burns maintains Nuvation Bio (NYSE:NUVB) with a Buy and raises the price target from $10 to $18.